Takeda signs $882m rare disease alliance with Oxford biotech EvoxEvox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, Share XTakeda signs $882m rare disease alliance with Oxford biotech Evoxhttps://pharmaphorum.com/news/takeda-signs-882m-rare-disease-alliance-with-oxford-biotech-evox/
9th Annual Biologics Formulation Development and Drug Delivery ForumFormulation development for Safe Delivery to patient Share X9th Annual Biologics Formulation Development and Drug Delivery Forumhttps://pharmaphorum.com/events/9th-annual-biologics-formulation-development-and-drug-delivery-forum/